CMO Annual Report 2020- 2021

76 Chief Medical Officer for Scotland Annual Report 2020 -2021 129. Licchetta, M, & Stelmach, M. Fiscal sustainability analytical paper: Fiscal sustainability and public spending on health. Office for Budget Responsibility, 2016 Available from: https://obr.uk/docs/dlm_uploads/ Health-FSAP.pdf [Accessed 19th February 2021] 130. The Organisation for Economic Co-operation and Development. Tackling Wasteful Spending on Health, OECD Publishing, Paris,2017. Available from: https://www.oecd-ilibrary.org/social-issues-migration- health/tackling-wasteful-spending-on-health_9789264266414-en [Accessed 19th February 2020] 131. Aus der Beek T, Weber FA, Bergmann A, Hickmann S, Ebert I, Hein A, Küster A. Pharmaceuticals in the environment—Global occurrences and perspectives. Environmental toxicology and chemistry. 2016;35(4):823-35 132. Wellcome, US Centers for Disease Control and Prevention and UK Science and Innovation Network. Initiatives for Addressing Antimicrobial Resistance in the Environment: Current Situation and Challenges. London : Wellcome Trust, 2018. Available from: https://wellcome.org/sites/default/files/antimicrobial- resistance-environment-report.pdf [Accessed 19th February 2020] 133. Mortimer F, Isherwood J, Wilkinson A, Vaux E. Sustainability in quality improvement: redefining value. Future healthcare journal. 2018 ;5(2):88 134. Janson C, Henderson R, Löfdahl M, Hedberg M, Sharma R, Wilkinson AJ. Carbon footprint impact of the choice of inhalers for asthma and COPD. Thorax. 2020 ;75(1):82-4

RkJQdWJsaXNoZXIy MjA4NTgz